METFORMIN\VILDAGLIPTIN: 2,890 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,890
Total FAERS Reports
230 (8.0%)
Deaths Reported
887
Hospitalizations
2,890
As Primary/Secondary Suspect
301
Life-Threatening
57
Disabilities
Active Ingredient: METFORMIN HYDROCHLORIDE\VILDAGLIPTIN ·
First Report: 10200220 · Latest Report: 20250916
What Are the Most Common METFORMIN\VILDAGLIPTIN Side Effects?
#1 Most Reported
Blood glucose increased
346 reports (12.0%)
#2 Most Reported
Lactic acidosis
279 reports (9.7%)
#3 Most Reported
Hyperglycaemia
236 reports (8.2%)
All METFORMIN\VILDAGLIPTIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 346 | 12.0% | 4 | 81 |
| Lactic acidosis | 279 | 9.7% | 33 | 171 |
| Hyperglycaemia | 236 | 8.2% | 1 | 30 |
| Acute kidney injury | 191 | 6.6% | 12 | 112 |
| Diabetes mellitus | 189 | 6.5% | 5 | 26 |
| Malaise | 186 | 6.4% | 6 | 66 |
| Hypertension | 163 | 5.6% | 6 | 26 |
| Diarrhoea | 152 | 5.3% | 2 | 53 |
| Diabetes mellitus inadequate control | 137 | 4.7% | 1 | 19 |
| Glycosylated haemoglobin increased | 136 | 4.7% | 0 | 12 |
| Weight decreased | 133 | 4.6% | 2 | 39 |
| Blood pressure increased | 126 | 4.4% | 2 | 31 |
| Vomiting | 123 | 4.3% | 2 | 78 |
| Hypoglycaemia | 117 | 4.1% | 10 | 45 |
| Drug ineffective | 113 | 3.9% | 1 | 26 |
| Dizziness | 112 | 3.9% | 2 | 26 |
| Fatigue | 102 | 3.5% | 1 | 36 |
| Death | 100 | 3.5% | 100 | 3 |
| Memory impairment | 100 | 3.5% | 0 | 22 |
| Headache | 98 | 3.4% | 0 | 33 |
Who Reports METFORMIN\VILDAGLIPTIN Side Effects? Age & Gender Data
Gender: 53.2% female, 46.8% male. Average age: 64.8 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is METFORMIN\VILDAGLIPTIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 5 | 0 | 0 |
| 2006 | 3 | 0 | 0 |
| 2007 | 2 | 0 | 0 |
| 2008 | 8 | 0 | 1 |
| 2009 | 5 | 0 | 2 |
| 2010 | 14 | 1 | 6 |
| 2011 | 10 | 2 | 2 |
| 2012 | 28 | 2 | 9 |
| 2013 | 43 | 3 | 16 |
| 2014 | 71 | 4 | 29 |
| 2015 | 84 | 9 | 32 |
| 2016 | 86 | 8 | 36 |
| 2017 | 155 | 19 | 44 |
| 2018 | 193 | 14 | 88 |
| 2019 | 294 | 26 | 94 |
| 2020 | 377 | 19 | 99 |
| 2021 | 187 | 16 | 65 |
| 2022 | 125 | 5 | 52 |
| 2023 | 29 | 1 | 13 |
| 2024 | 10 | 0 | 7 |
| 2025 | 7 | 1 | 0 |
What Is METFORMIN\VILDAGLIPTIN Used For?
| Indication | Reports |
|---|---|
| Diabetes mellitus | 1,291 |
| Type 2 diabetes mellitus | 726 |
| Product used for unknown indication | 691 |
| Blood glucose increased | 45 |
| Blood glucose abnormal | 44 |
| Diabetes mellitus management | 16 |
| Hyperglycaemia | 8 |
| Hypertension | 7 |
| Type 1 diabetes mellitus | 7 |
| Blood glucose | 6 |
METFORMIN\VILDAGLIPTIN vs Alternatives: Which Is Safer?
METFORMIN\VILDAGLIPTIN vs METHADONE
METFORMIN\VILDAGLIPTIN vs METHAMPHETAMINE
METFORMIN\VILDAGLIPTIN vs METHENAMINE HIPPURATE
METFORMIN\VILDAGLIPTIN vs METHIMAZOLE
METFORMIN\VILDAGLIPTIN vs METHOCARBAMOL
METFORMIN\VILDAGLIPTIN vs METHOHEXITAL
METFORMIN\VILDAGLIPTIN vs METHOTREXATE
METFORMIN\VILDAGLIPTIN vs METHOXSALEN
METFORMIN\VILDAGLIPTIN vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
METFORMIN\VILDAGLIPTIN vs METHYL ALCOHOL
Official FDA Label for METFORMIN\VILDAGLIPTIN
Official prescribing information from the FDA-approved drug label.